Bone morphogenetic protein (BMP) signaling regulates many different developmental and homeostatic processes in metazoans. The BMP pathway is conserved in Caenorhabditis elegans, and is known to regulate body size and mesoderm development. We have identified the C. elegans smoc-1 (Secreted MOdular Calcium-binding protein-1) gene as a new player in the BMP pathway. smoc-1(0) mutants have a small body size, while overexpression of smoc-1 leads to a long body size and increased expression of the RAD-SMAD (reporter acting downstream of SMAD) BMP reporter, suggesting that SMOC-1 acts as a positive modulator of BMP signaling. Using double-mutant analysis, we showed that SMOC-1 antagonizes the function of the glypican LON-2 and acts through the BMP ligand DBL-1 to regulate BMP signaling. Moreover, SMOC-1 appears to specifically regulate BMP signaling without significant involvement in a TGFb-like pathway that regulates dauer development. We found that smoc-1 is expressed in multiple tissues, including cells of the pharynx, intestine, and posterior hypodermis, and that the expression of smoc-1 in the intestine is positively regulated by BMP signaling. We further established that SMOC-1 functions cell nonautonomously to regulate body size. Human SMOC1 and SMOC2 can each partially rescue the smoc-1(0) mutant phenotype, suggesting that SMOC-1's function in modulating BMP signaling is evolutionarily conserved. Together, our findings highlight a conserved role of SMOC proteins in modulating BMP signaling in metazoans.
specification, and cell death throughout metazoan development (Wang et al. 2014) . Tight regulation of BMP signaling in time, space, magnitude, and duration is therefore important for proper developmental outcomes. Misregulation of BMP signaling can cause a variety of disorders in humans (Brazil et al. 2015; Salazar et al. 2016; Wu et al. 2016) . Previous studies have demonstrated that BMP signaling can be regulated at many levels, both extracellularly and intracellularly (Bragdon et al. 2011; Lowery et al. 2016; Sedlmeier and Sleeman 2017) . The nematode Caenorhabditis elegans provides a useful system for identifying factors that modulate the BMP pathway.
The BMP pathway in C. elegans is comprised of evolutionarily conserved core components including the ligand (DBL-1/BMP), the type I and type II receptors (SMA-6/RI and DAF-4/RII), the R-Smads (SMA-2 and SMA-3), and the co-Smad (SMA-4) (Estevez et al. 1993; Savage et al. 1996; Krishna et al. 1999; Morita et al. 1999 Morita et al. , 2002 Suzuki et al. 1999 ) ( Figure 1A ). Unlike in Drosophila and vertebrates, BMP signaling is not essential for viability in C. elegans, yet it regulates multiple processes, including body size, male tail development, and mesoderm patterning (Gumienny and Savage-Dunn 2013; Savage-Dunn and Padgett 2017) . The BMP ligand DBL-1 is expressed in the ventral nerve cord (Suzuki et al. 1999) and it activates the pathway in the hypodermis to regulate body size (Yoshida et al. 2001; Wang et al. 2002) . Reduced BMP signaling causes a small (Sma) body size, while increased BMP signaling leads to a long (Lon) body size (Morita et al. 1999 (Morita et al. , 2002 Suzuki et al. 1999) . BMP signaling also regulates the development of the postembryonic mesoderm lineage, the M lineage. We have shown that mutations in the BMP pathway specifically suppress the M-lineage dorsoventral patterning defects caused by mutations in sma-9, which encodes the C. elegans zinc finger protein Schnurri (Liang et al. 2003; Foehr et al. 2006) . Specifically, mutations in sma-9 result in the loss of the two M-derived coelomocytes (CCs), while BMP pathway mutations can restore these two CCs in the sma-9(0) mutant background (Foehr et al. 2006; Liu et al. 2015; Wang et al. 2017) (Figure 1 , B and C). Using this suppression of sma-9(0) M-lineage defect (Susm) assay, we have identified multiple evolutionarily conserved modulators of BMP signaling. These include the RGM (repulsive guidance molecule) protein DRAG-1 (Tian et al. 2010) , the neogenin homolog UNC-40 (Tian et al. 2013) , the ADAM10 protein SUP-17 (Wang et al. 2017) , and three tetraspanins, TSP-21, TSP-12, and TSP-14 (Liu et al. 2015; Wang et al. 2017) .
In this study, we report the identification and characterization of a new BMP modulator, which we have named SMOC-1 (Secreted MOdular Calcium-binding protein-1). SMOC-1 is predicted to be a secreted protein that contains a thyroglobulin-like (TY) domain and an extracellular calcium (EC)-binding motif. We show here that SMOC-1 acts as a positive modulator of BMP signaling in C. elegans. We further demonstrate that SMOC-1 acts genetically upstream of the BMP ligand and functions in a positive feedback loop to promote BMP signaling in regulating body size. We identified smoc-1-expressing cells, and demonstrated that SMOC-1 acts cell nonautonomously to regulate BMP signaling. Finally, we provide evidence that the function of SMOC proteins in the BMP pathway is conserved from worms to humans.
Materials and Methods

C. elegans strains
All strains were maintained at 20°C using standard culture conditions (Brenner 1974 ) unless otherwise specified. Table  1 lists all the strains used in this study.
Plasmid constructs and transgenic lines
All plasmid constructs used in this study are listed in Table 2 . The smoc-1 open reading frame was amplified from the Vidal RNA interference library (Rual et al. 2004) . Subsequent sequencing of the clone revealed the presence of a point mutation (S103P, Figure 2D ), changing amino acid 103 from serine (TCC) to proline (CCC). Site-directed mutagenesis was used to fix this point mutation. Plasmids containing the human SMOC1 and SMOC2 cDNAs were purchased from PlasmID, the DNA resource core at Harvard Medical School.
Transgenic strains were generated using the plasmids pRF4 (rol-6(su1006)), pCFJ90 (myo-2p::mCherry::unc-54 3'UTR), or pJKL724 (myo-3p::mCherry::unc-54 39 UTR) as co-injection markers. Two transgenic lines with the best transmission efficiencies were analyzed for each plasmid of interest. Integrated transgenic lines either overexpressing smoc-1 (jjIs5119) or carrying the smoc-1 transcriptional reporter (jjIs4688 and jjIs4694) were generated using g-irradiation, followed by three rounds of outcrossing with N2 worms.
Protein sequence alignment
Sequences were taken from GenBank [C. elegans SMOC-1 (T04F3.2), 179609; C. remanei CRE_26999, 9815068; C. briggsae CBG23276, 8578577; Drosophila melanogaster Pent/Magu, 44850; Homo sapiens SMOC1, 64093; and H. sapiens SMOC2, 64094] or WormBase (C. brenneri CBN20462, C. japonica CJA07338, and Pristionchus pacificus PPA34808). TY and EC domains in SMOC proteins were predicted by Interpro (Finn et al. 2017) . Domains were aligned using the M-COFFEE Multiple Sequence Alignment tool on the T-COFFEE server (version 11.00.d625267; Wallace et al. 2006) . ALN files were processed to produce alignment images using BOXSHADE.
Microscopy
Epifluorescence and differential interference contrast (DIC) microscopy were conducted on a Leica DMRA2 compound microscope equipped with a Hamamatsu Orca-ER camera (B and C) Merged DIC and GFP images of L4 stage sma-9(cc604) (B) and smoc-1(tm7125); sma-9(cc604) (C) worms carrying the CC::gfp CC marker. Arrows indicate M-derived CCs. Asterisks (*) denote embryonically-derived CCs. BMP, bone morphogenetic protein; CC, coelomocyte; RI, type I receptor; RII, type II receptor; R-Smad, receptor-regulated Smad; Co-Smad, common mediator Smad. using the iVision software (Biovision Technology). Subsequent image analysis was performed using Fiji (Schindelin et al. 2012) . The RAD-SMAD reporter assay was carried out as previously described (Tian et al. 2013) .
Body size measurements
Body size measurement assays were conducted as previously described (Tian et al. 2013) . Hermaphrodite animals at the gravid adult stage were collected and treated with hypochlorite. The resulting embryos were allowed to hatch in M9 buffer at 16°. Synchronized L1s were plated onto NGM plates and allowed to grow at 20°. Worms were washed off the plates, treated with 0.3% sodium azide, and mounted onto 2% agarose pads. Hermaphrodite worms were imaged at the L4.3 stage based on vulval development (Mok et al. 2015) . Images were taken by a Hamamatsu Orca-ER camera using the iVision software (Biovision Technology). Body sizes were measured from images using the segmented line tool of Fiji. An ANOVA and Tukey's honest significant difference (HSD) were conducted to test for differences in body size between genotypes using R (R Core Team 2015).
Suppression of sma-9(0) M-lineage defect assay
For the suppression of sma-9(0) M-lineage defect (Susm) assay, worms were grown at 20°, and then the number of animals with four CCs and six CCs were tallied across three to seven plates for each genotype. For the Susm rescue experiments shown in Figure 7B and Figure 8B , we used R to generate a general linear model with binomial error and a logit link function designating transgenic state as the explanatory function. The Wald statistic was used to determine if transgenic state (transgenic vs. nontransgenic worms within the same line) is associated with CC number.
Dauer formation assay
Dauer formation assay was conducted under nondauerinducing conditions as previously described (Vowels and Thomas 1992) . Ten adult hermaphrodites were placed on a 6-cm NGM plate (five plates per strain at each temperature) and allowed to lay eggs for , 8 hr. Adults were removed and plates were placed at the test temperature. When nondauer worms became young adults, the numbers of dauer and nondauer worms on each plate were scored. Using R, we tested for differences in dauer formation between genotypes using an ANOVA followed by Tukey's HSD.
Data availability
Strains and plasmids are available upon request. The authors affirm that all data necessary for confirming the conclusions of the article are present within the article, figures, and tables.
Results
Mutations in T04F3.2 suppress the mesoderm defects of sma-9(0) mutants
In a previous sma-9 suppressor screen, we uncovered a novel complementation group named susm-1 that includes three alleles, jj65, jj85, and jj180 (Liu et al. 2015) (Table 3) , which suppressed the sma-9(0) M-lineage defect at high penetrance. Whole-genome sequencing (WGS) of the three alleles using the SNP-WGS method described in Liu et al. (2015) identified molecular lesions in the uncharacterized gene T04F3.2: jj65 and jj85 are missense mutations C210Y and E105K, respectively, while jj180 is a nonsense mutation denoted Q180Stop ( Figure 2 , A and B). To confirm that T04F3.2 is the corresponding gene for this complementation group, we obtained two deletion alleles that delete most of the coding region of T04F3.2, tm7000, and tm7125 ( Figure  2A ), and found that both alleles suppressed the sma-9(0) M-lineage defect to near 100% ( Figure 1C and Table 3 ). Pairwise complementation tests between tm7000 and jj65, jj85, or jj180, showed that tm7000 failed to complement all three alleles in their suppression of the sma-9(0) M-lineage defect (Table 3) . Subsequent sma-9(0) suppressor screens conducted in the laboratory identified three additional alleles of this complementation group: jj109, jj115, and jj139. WGS followed by Sanger sequencing showed that all three alleles contain nonsense mutations in T04F3.2: W13Stop for both jj115 and jj139, and W176Stop for jj109 ( Figure  2, A and B ). Finally, a transgene containing the T04F3.2 genomic region including 2-kb upstream sequences, the entire coding region with introns, and 2-kb downstream sequences rescued the sma-9(0) suppression phenotype of tm7125 mutants (Table 3) . Collectively, these results demonstrated that T04F3.2 is the corresponding gene for the susm-1 locus. The nature of the molecular lesions in tm7000, tm7125, jj109, jj115, jj139, and jj180, the near 100% penetrance of their Susm phenotypes, and their similar body size phenotypes (see below), suggest that all of these alleles are putative null alleles. For ease of genotyping, most of our subsequent analysis was carried out using the tm7125 allele.
T04F3.2 encodes a predicted SMOC protein: SMOC-1 T04F3.2 is predicted to encode a protein of 260 amino acids. It contains a predicted signal peptide, a TY domain, and a secreted protein acidic and rich in cysteine (SPARC) EC-binding region ( Figure 2 ). The EC domain is predicted to contain a pair of helix-loop-helix EF hand calcium-binding motifs (Hohenester et al. 1996; Vannahme et al. 2002) . The predicted T04F3.2 protein is most similar to the human secreted modular calcium-binding proteins SMOC1 and SMOC2 (Vannahme et al. 2002 (Vannahme et al. , 2003 , and the D. melanogaster SMOC homolog Pentagone/Magu (Vuilleumier et al. 2010) . A Basic Local Alignment Search Tool search against the C. elegans genome showed that T04F3.2 is the only SMOC homolog. Therefore, we have named this gene smoc-1 and its corresponding protein SMOC-1. SMOC proteins are matricellular proteins that are in the same family as SPARC/BM-40/osteonectin (Bradshaw 2012) . The domain arrangement of SMOC proteins varies across species. The C. elegans SMOC-1 protein is predicted to have one TY domain, one EC domain, and completely lack the follistatin domain that is present in other SMOC proteins ( Figure 2C ). Within the TY domain, SMOC-1 shares 30% amino acid identity and 50% similarity with human SMOC1 and SMOC2, and contains a CWCV tetrapeptide sequence and an additional four conserved cysteines that are characteristic of the TY domain ( Figure 2D ). The EC domain of SMOC-1 shares 25% amino acid identity and 45% similarity with those of the human SMOC proteins. Among the conserved residues in the EC domain are four cysteines thought to be involved in disulfide-bond formation (Busch et al. 2000) .
The locations of the molecular lesions in our smoc-1 mutant alleles suggest that both the TY and EC domains are important for SMOC-1 function. jj85 is a mutation in the TY domain, changing amino acid 105 from a glutamic acid to a lysine (E105K, Figure 2, B and D) . Although the change appears to make this residue more similar to its counterpart (arginine or lysine) in the fly and human SMOC proteins ( Figure 2D ), we noted that E105 is conserved in multiple nematode species ( Figure 2F ). We also obtained a smoc-1 cDNA clone that has a single-base mutation changing amino acid 103 from a conserved serine to proline ( Figure 2D ). This mutant smoc-1 cDNA (S103P) failed to rescue the smoc-1(0) Susm phenotype, while the wild-type (WT) smoc-1 cDNA under the same regulatory elements successfully rescued the smoc-1(0) Susm phenotype (Table 3) , again highlighting the importance of the TY domain for SMOC-1 function.
Similarly, the EC domain is also critical for SMOC-1 function, because a change of the conserved cysteine residue at amino acid 210 to tyrosine (C210Y) in jj65 significantly compromised the function of SMOC-1 (Figure 2 , B and E and Table 3 ).
SMOC-1 functions within the BMP pathway to positively regulate BMP signaling
We have previously shown that mutations in BMP pathway components specifically suppress the sma-9(0) M-lineage defect (Foehr et al. 2006; Liu et al. 2015) . The highly penetrant Susm phenotype of multiple smoc-1 alleles suggests that SMOC-1 may function in the BMP pathway. BMP pathway mutants are known to exhibit altered body sizes (Savage-Dunn and Padgett 2017) . We measured the body sizes of smoc-1 single-mutant animals and found that they all have a reproducibly smaller body size (95%) compared to WT animals at the same developmental stage (Figure 3, A, B , and D). This smaller body size can be rescued by a WT smoc-1 transgene ( Figure 3D ). Moreover, transgenic smoc-1 mutant animals carrying this transgene are significantly longer than WT animals ( Figure 3D ). The increased body size is likely Table 3 Mutations in smoc-1 suppress the sma-9(0) M-lineage defects Genotype Susm penetrance a (# of animals examined) sma-9(cc604) smoc-1(jj65); sma-9(cc604) 84% (N = 255) b smoc-1(jj85); sma-9(cc604) 78% (N = 240) b smoc-1(jj180); sma-4(jj70); sma-9(cc604) 98% (N = 80) b,c smoc-1(jj180); sma-9(cc604) 98% (N = 319) c sma-4(jj70); sma-9(cc604) 0% (N . 100) c sma-4(e729); sma-9(cc604) 100% (N = 61) d smoc-1(tm7000); sma-9(cc604) 97% (N = 134) smoc-1(tm7125); sma-9(cc604) 98% (N = 686) smoc-1(tm7000)/jj65 or +/jj65; sma-9(cc604) 67% (N = 51) e smoc-1(tm7000)/jj85 or +/jj85; sma-9(cc604) 46% (N = 24) e smoc-1(tm7000)/jj180 or +/jj180; sma-9(cc604) 58% (N = 26) e smoc-1(jj109); sma-9(cc604) 99% (N = 107) smoc-1(jj115); sma-9(cc604) 100% (N = 95) smoc-1(jj139); sma-9(cc604) 100% (N = 128) smoc-1(tm7125); sma-9(cc604); jjEx4490[smoc-1p::smoc-1 genomic::smoc-1 39UTR], line 1 32% (N = 111) smoc-1(tm7125); sma-9(cc604); jjEx4491[smoc-1p::smoc-1 genomic::smoc-1 39UTR], line 2 26% (N = 101) smoc-1(tm7125); sma-9(cc604); jjEx4810[smoc-1p::smoc-1 cDNA::smoc-1 39UTR], line 1 2% (N = 278) smoc-1(tm7125); sma-9(cc604); jjEx4811[smoc-1p::smoc-1 cDNA::smoc-1 39UTR], line 2 1% (N = 498) smoc-1(tm7125); sma-9(cc604); jjEx4812[smoc-1p::smoc-1 cDNA::unc-54 39UTR], line 1 17% (N = 481) smoc-1(tm7125); sma-9(cc604); jjEx4813[smoc-1p::smoc-1 cDNA::unc-54 39UTR], line 2 23% (N = 792) smoc-1(tm7125); sma-9(cc604); jjEx4650[hlh-8p::smoc-1 cDNA::unc-54 39UTR], line 1 15% (N = 186) smoc-1(tm7125); sma-9(cc604); jjEx4612[hlh-8p::smoc-1 cDNA::unc-54 39UTR], line 3 17% (N = 214) smoc-1(tm7125); sma-9(cc604); jjEx4620[hlh-8p::smoc-1 cDNA-S103P::unc-54 39UTR], line 1 86% (N = 95) smoc-1(tm7125); sma-9(cc604); jjEx4674[hlh-8p::smoc-1 cDNA-S103P::unc-54 39UTR], line 2 92% (N = 100) CC, coelomocyte; Susm, suppression of sma-9(0) M-lineage defect. a The Susm penetrance refers to the percent of animals with one or two M-derived CCs as scored by the CC::GFP reporter. b Data taken from Liu et al. (2015) . c The jj70 strain described in our previous publication (Liu et al. 2015) carries a mutation in sma-4(S110L), as well as a mutation in smoc-1 (Q180Stop). To avoid confusion, we have designated the sma-4 mutation as jj70, and the mutation in smoc-1 as jj180. As shown here, sma-4(jj70) failed to suppress sma-9(0), while smoc-1(jj180) suppressed sma-9(0). d Data taken from Foehr et al. (2006) . e Complementation tests were performed by crossing tm7000/+; cc604 males with jj65 (jj85 or jj180); cc604 hermaphrodites and scoring the cross progeny for the number of CCs. All progeny would have four CCs if the tested alleles complemented each other, while 50% of the progeny would have six CCs if the tested alleles failed to complement each other. The partial dominance of each of the jj alleles tested (Liu et al. 2015) may have contributed to the observed percentage being slightly above 50%.
caused by the presence of multiple gene copies within the transgene generated using standard C. elegans transgenic approaches, which often results in overexpression of the gene (Mello et al. 1991) . We have subsequently integrated the smoc-1 transgene in the WT background (jjIs5119 ,  Table 1 ). Again, jjIs5119 [which we have referred to as smoc-1(OE)] animals are significantly longer than WT animals ( Figure 4B ). Thus, smoc-1 appears to function in a dosedependent manner to positively regulate body size.
To determine whether smoc-1 functions within the BMP pathway to regulate body size, we generated double mutants between smoc-1(tm7125) and null mutations in various BMP pathway components, and measured their body lengths. As shown in Figure 4A , dbl-1(ok3749) smoc-1(tm7125) double mutants were as small as dbl-1(ok3749) single mutants. Similarly, sma-3(jj3); smoc-1(tm7125) and sma-6(jj1); smoc-1(tm7125) double mutants were as small as sma-3(jj3) and sma-6(jj1) single mutants, respectively. These observations indicate that smoc-1 functions within the BMP pathway, rather than in a parallel pathway, to regulate body size.
In addition to body size, BMP pathway mutants also exhibit male tail defects and the mutant males cannot mate (Savage et al. 1996; Krishna et al. 1999; Suzuki et al. 1999) . We generated smoc-1(tm7125) males and found that they mated well with WT hermaphrodites to produce cross progeny, suggesting that smoc-1(tm7125) males do not have severe male tail-patterning defects. This is not surprising as previous studies have demonstrated that male tail development is not affected when there is a partial reduction of BMP signaling .
We also examined the expression of the RAD-SMAD reporter, which we have previously shown serves as a direct readout of BMP signaling (Tian et al. 2010) . While smoc-1(tm7125) mutants did not exhibit significant changes in the expression of the RAD-SMAD reporter (data now shown), the smoc-1(OE) lines showed a significant increase in the level of RAD-SMAD reporter expression ( Figure 4 , G and H). We reasoned that the change of RAD-SMAD reporter expression in smoc-1(tm7125) mutants may be too small to detect, given that smoc-1(tm7125) mutants only exhibit a 5% reduction in body size compared to WT animals (see above). Nevertheless, our findings are consistent with SMOC-1 acting in the BMP pathway to positively promote BMP signaling.
SMOC-1 functions through the BMP ligand to promote BMP signaling in regulating body size
The long body size phenotype caused by smoc-1 overexpression provided us with a useful tool to determine where in the BMP signaling pathway SMOC-1 functions. We conducted genetic epistasis analysis by generating double mutants between smoc-1(OE) and null mutations in core components of the BMP pathway that are known to cause a small body size. As shown in Figure 4B , smoc-1(OE); dbl-1(ok3749) double mutants and smoc-1(OE); sma-3(tm4625) double mutants are as small as dbl-1(ok3749) and sma-3(tm4625) single mutants, respectively. These results provide further support for the conclusion that SMOC-1 functions within the BMP pathway to regulate body size. More importantly, our genetic epistasis results demonstrate that SMOC-1 functions upstream of the BMP ligand DBL-1 in the same genetic pathway to regulate body size, and that the function of SMOC-1 as a positive modulator of body size is dependent on DBL-1.
SMOC-1 and LON-2/glypican function antagonistically to modulate BMP signaling in regulating body size
Previous studies have shown that the glypican LON-2 functions genetically upstream of DBL-1/BMP and acts as a (D) Relative body length of developmental stage-matched WT and various smoc-1 mutant worms. Each smoc-1 mutant allele was outcrossed with N2 for at least three times, and two independent isolates for each allele (#s following the allele name) were used for body size measurement. The smoc-1(+) transgene was pMSD4[2 kb smoc-1p::smoc-1 cDNA::2 kb smoc-1 39UTR]. The body length of WT worms was set to 1.0. Error bars represent 95% C.I. An ANOVA followed by Tukey's honest significant difference was used to test for differences between genotypes. *** P , 0.0001. WT, wild-type. For (A, B, and D) , an ANOVA followed by Tukey's honest significant difference was used to test for differences between genotypes. *** P , 0.0001. ND, no difference; WT, wild-type. negative regulator of BMP signaling (Gumienny et al. 2007 ). We performed double-mutant analysis, and dissected the relationship between SMOC-1 and LON-2/glypican. We first measured the body length of double-null mutants between smoc-1 and lon-2. As shown in Figure 5A , smoc-1(tm7125); lon-2(e678) double-null mutants exhibited an intermediate body size compared to either single-null mutant. In particular, the body size of smoc-1(tm7125); lon-2(e678) double mutants is similar to WT animals. These observations suggest that SMOC-1 and LON-2/glypican antagonize each other in regulating body size. Interestingly, smoc-1(OE); lon-2(e678) worms are longer than either smoc-1(OE) animals or lon-2(e678) single mutants ( Figure 5B) . Thus, overexpressing smoc-1 is capable of further increasing the body size of worms that completely lack LON-2/glypican. Taken together, our genetic analysis between lon-2 and smoc-1 suggests that SMOC-1 and LON-2/glypican function independently and antagonistically to modulate BMP signaling in regulating body size.
SMOC-1 does not play a major role in the TGFb-like dauer pathway
In addition to the BMP pathway, C. elegans has a TGFb-like signaling pathway that regulates dauer development (Savage-Dunn and Padgett 2017) . To determine if SMOC-1 plays a role in the TGFb-like dauer pathway, we first assayed dauer formation of worms with different levels of smoc-1 expression. smoc-1(tm7125) and smoc-1(OE) single-mutant worms did not exhibit any constitutive or defective dauer formation phenotype at any of the temperatures tested (Table 4 , data not shown), suggesting that SMOC-1 does not play a major role in the TGFb-like dauer pathway. Next, we generated double-mutant worms carrying both smoc-1(tm7125) and mutations in the TGFb ligand DAF-7/TGFb or the type 1 receptor DAF-1/RI (Georgi et al. 1990; Ren et al. 1996) , and examined them for the constitutive dauer formation (Daf-c) phenotype (Table 1) . While smoc-1(tm7125) partially suppressed the Daf-c phenotype of daf-7(e1372) at 20°, a similar trend was not observed at either 15 or at 25°. Similarly, smoc-1(tm7125) did not exhibit any consistent suppression or enhancement of the Daf-c phenotype of two daf-1 mutant alleles (Table 4 ). These results suggest that SMOC-1 does not play a major role in the TGFb-like dauer pathway, although we cannot rule out a minor buffering function of SMOC-1 in this pathway.
Because of the genetic interaction that we observed between smoc-1 and lon-2, we also tested whether LON-2/ glypican plays a role in the TGFb-like dauer pathway by performing similar double-mutant analysis as described for smoc-1. At 20°, lon-2(e678) showed partial suppression of the Daf-c phenotype of daf-7(e1372) ( Table 5 ), but a similar trend was not observed at 15 or at 25° (Table 5 ). As seen with smoc-1(tm7125), lon-2(e678) also did not consistently enhance or suppress the Daf-c phenotype of a TGFb receptor mutation, daf-1(m213). Thus, like SMOC-1, LON-2 does not appear to play a major role, but may play a minor modulatory role, in the TGFb dauer pathway.
smoc-1 is expressed in the pharynx, intestine, and posterior hypodermis
Since smoc-1 is predicted to encode a secreted protein, we first attempted to identify the cells that express smoc-1. As described above, a smoc-1 genomic fragment containing 2-kb upstream sequences, the entire coding region with introns, and 2-kb downstream sequences (pJKL1128, Table 2) can rescue the Susm and body size phenotypes of smoc-1(tm7125) mutants ( Figure 6A and Table 3 ). The same promoter element driving the smoc-1 cDNA with its own 39-UTR or with the unc-54 39-UTR rescued both the small body size and the Susm phenotypes of smoc-1(tm7125) mutants (Figure 6A and Table 3 ), suggesting that the regulatory elements required for SMOC-1 function in BMP signaling reside in the 2-kb upstream sequences. Therefore, we generated a transcriptional reporter pJKL1139[smoc-1 2 kb promoter::4xnls:: gfp::unc-54 39UTR] (Table 2) . We also generated two additional transcriptional reporters using 5-kb smoc-1 upstream sequences (pJKL1201[smoc-1 5kb promoter::4xnls::gfp::unc-54 39UTR] and pJKL1202[smoc-1 5kb promoter::4xnls::gfp::2 kb smoc-1 39UTR], Table 2 ). All three reporters showed similar expression patterns in transgenic animals. Therefore, we focused on Relative body length of developmental stage-matched WT (set to 1.0) and various mutant worms, including double mutants between smoc-1(tm7125) null and lon-2(e678) null (A), and double mutants between smoc-1(OE) and lon-2(e678) null (B). The body size of smoc-1(tm7125); lon-2(e678) double-null mutants is similar to that of WT animals, while smoc-1(OE); lon-2(e678) double mutants are longer than either one. Error bars represent 95% C.I. An ANOVA followed by Tukey's honest significant difference was used to test for differences between genotypes. * P , 0.01, ** P , 0.001, and *** P , 0.0001. ND, no difference; WT, wild-type.
pJKL1139[smoc-1 2 kb promoter::4xnls::gfp::unc-54 39UTR] and generated integrated transgenic lines carrying this reporter (jjIs4688 and jjIs4694, Table 1 ) for further analysis.
The integrated smoc-1 transcriptional reporter showed strong GFP expression. GFP was first detectable in several cells located in the anterior of bean-stage embryos ( Figure  6E ). In the developing larvae, GFP is expressed in cells of the pharynx, the intestine, and the posterior hypodermis ( Figure  6B ). Pharyngeal cells expressing smoc-1p::gfp include the epithelial cells e2, the marginal cells mc1 and mc2, the M4 neuron, and all six of the pharyngeal/intestinal valve cells ( Figure 6C ). Cells of the posterior hypodermis expressing smoc-1p::gfp include hyp8, hyp9, hyp10, and hyp11 ( Figure  6D ). Expression in these tissues persisted from the L1 larval stage through adulthood. We noted that while all transgenic animals showed GFP expression in the pharynx and the posterior hypodermis, a small fraction of animals (8%) did not exhibit GFP expression in all or some of the intestinal cells ( Figure 6G ). We observed no GFP expression in any other tissues, including the nerve cord, body wall muscles (BWMs), or the M lineage. Thus, smoc-1 is expressed in cells of the pharynx, intestine, and posterior hypodermis.
Intestinal expression of smoc-1 is positively regulated by BMP signaling
We next asked whether smoc-1 expression is regulated by the BMP pathway or by SMOC-1 itself. We introduced the integrated smoc-1 transgenic reporter into BMP pathway null mutants, including sma-3(jj3), sma-6(jj1), lon-2(e678), and smoc-1(tm7125) mutants (Table 1) , and examined the expression pattern of the GFP reporter. Intriguingly, while the expression pattern and expression level of the GFP reporter in the pharynx and posterior hypodermis remained relatively constant in all mutant backgrounds examined, in sma-6(jj1) and sma-3(jj3) mutants there was a significant decrease in the percentage of animals that exhibited GFP expression in the intestinal cells, and a decrease in the intensity of intestinal GFP expression compared with WT animals (Figure 6, F and G) . There was also a moderate decrease in the percentage of animals showing intestinal GFP expression in smoc-1(tm7125) mutants ( Figure 6G ). In contrast, nearly 100% of lon-2(e678) animals showed bright intestinal GFP expression, as compared to 92% for WT animals ( Figure 6G ). Collectively, these results suggest that smoc-1 expression in the intestinal cells is positively regulated by BMP signaling.
We have shown that smoc-1(OE); dbl-1(ok3749) double mutants are as small as dbl-1(ok3749) single mutants ( Figure  4B ). Since expression of the smoc-1 transcriptional reporter is significantly reduced in intestinal cells of dbl-1(ok3749) mutants, it is possible that the small body size phenotype of smoc-1(OE); dbl-1(ok3749) double mutants is due to insufficient levels of smoc-1 expression in the dbl-1(ok3749) background. To address this question, we generated a new construct pJKL1217[dpy-30p::smoc-1 cDNA::unc-54 39UTR] (Table 2) , which drives ubiquitous smoc-1 expression under the control of the dpy-30 promoter. DPY-30 is an essential component of the C. elegans dosage compensation machinery (Hsu and Meyer 1994; Hsu et al. 1995) , and dpy-30 expression is not known to be regulated by BMP signaling. We found that WT worms carrying the [dpy-30p::smoc-1 cDNA::unc-54 39UTR] transgene are longer than WT worms (Figure 4, C and D) , just like the smoc-1(OE) strain described above. However, dbl-1(ok3749) mutants carrying the [dpy-30p::smoc-1 cDNA:: unc-54 39UTR] transgene are as small as dbl-1(ok3749) single mutants (Figure 4, E and F) . These findings demonstrate that SMOC-1 functions in a positive feedback loop to promote BMP signaling: SMOC-1 acts through the DBL-1/BMP ligand and its downstream Smad proteins to promote BMP signaling, while BMP signaling itself positively promotes the expression of smoc-1 in intestinal cells.
smoc-1 functions cell nonautonomously to regulate body size and M-lineage development
The smoc-1 transcriptional reporters identified cells in the pharynx, intestine, and posterior hypodermis as smoc-1expressing cells. To determine in which tissue(s) expression of smoc-1 is sufficient to regulate BMP signaling, we used a set of promoters to drive smoc-1 cDNA in a tissue-specific 0 (485) 44.9 6 7.4 (1059) 100 (964) daf-1(m40); smoc-1(tm7125) #1 0 (589) 57.2 6 16.4 (1567) a 99.9 6 0.2 (970) daf-1(m40); smoc-1(tm7125) #2 0 (483) 24.0 6 8.8 (721) a 100 (518) daf-1(m213) 0 (469) 99.4 6 0.6 (867) 100 (1174) daf-1(m213); smoc-1(tm7125) #1 0 (603) 98.2 6 3.1 (649) 100 (719) daf-1(m213); smoc-1(tm7125) #2 0 (544) 99.4 6 0.5 (676) 100 (378) n, number of worms scored at each temperature, from a total of five plates per genotype assayed at each condition. For each double-mutant combination, two independent isolates (#1 and #2) were examined. % Daf-c, mean dauer formation percentage 6 SD. a P , 0.05, as calculated by an ANOVA and Tukey's honest significant difference, between a double mutant and the corresponding daf single mutant at the specified temperature.
manner, and assayed for rescue of the smoc-1(tm7125) mutant phenotypes. Each construct was introduced into smoc-1(tm7125) worms for the body size assay, and into smoc-1(tm7125); sma-9(cc604) worms for the Susm assay. As shown in Figure 7A , forced expression of smoc-1 cDNA specifically within each individual smoc-1-expressing tissue [driven by ifb-2p for intestinal cells (Hüsken et al. 2008) or elt-3p for hypodermal cells (Gilleard et al. 1999) ] not only rescued the small body size of smoc-1(tm7125) mutants, but also made the transgenic worms longer, just like smoc-1 cDNA under the control of its own promoter. Forced expression of smoc-1 cDNA in tissues that do not express smoc-1 [driven by myo-2p for pharyngeal muscles (Okkema et al. 1993) , myo-3p for BWMs (Okkema et al. 1993) , or rab-3p for pan neurons (Nonet et al. 1997) ] also rescued the small body size of smoc-1(tm7125) mutants, and made the transgenic worms longer ( Figure 7A ). An exception is the lack of rescue of the body size phenotype in smoc-1(tm7125) mutants upon forced expression of smoc-1 cDNA in the M lineage using the hlh-8 promoter (Harfe et al. 1998 ). This could be due to the transient nature of hlh-8 promoter activity in undifferentiated M-lineage cells during larval development (Harfe et al. 1998) . We also crossed the [myo-2p::smoc-1 cDNA::unc-54 39UTR] transgene into dbl-1(ok3749) mutants. As shown in Figure 7B , the same transgene [myo-2p::smoc-1 cDNA::unc-54 39UTR] that caused a longer body size in smoc-1(tm7125) mutants did not increase the body size of dbl-1(ok3749) mutants. These observations, together with data presented in Figure 4 , firmly establish that SMOC-1's function in regulating body size is dependent on the BMP ligand DBL-1.
Similar to the body size rescue results, forced expression of smoc-1 cDNA in both smoc-1-expressing cells (intestine or hypodermis) and cells that do not normally express smoc-1 (pharyngeal muscles, BWMs, pan neurons, or the M lineage) rescued the Susm phenotype of smoc-1(tm7125) mutants ( Figure 7B ), although for reasons currently unknown, the rescuing efficiency appeared lower when smoc-1 expression was forced in BWMs or neurons ( Figure 7C ). Taken together, our results demonstrate that SMOC-1 can function cell nonautonomously to regulate both body size and M-lineage patterning. This is consistent with SMOC-1 being a putative secreted protein.
Human SMOC proteins can partially rescue the smoc-1(0) mutant phenotype in C. elegans
As described above, SMOC-1 has two human homologs, SMOC1 (hSMOC1) and SMOC2 (hSMOC2). We next asked whether either of the human SMOCs can substitute for SMOC-1 function in C. elegans. We first generated plasmids by directly putting the coding region of hSMOC1 or hSMOC2 in between the 2-kb smoc-1 promoter and the unc-54 39-UTR ( Figure 8A and Table 2 ), and tested their functionality using the Susm assay. Neither hSMOC1 nor hSMOC2 rescued the Susm phenotype of smoc-1(tm7125) worms ( Figure 8B ). We reasoned that the lack of rescue may be due to differences in the signal peptide between humans and C. elegans, causing the proteins to not be properly secreted from cells (Tian et al. 2010) . We next generated plasmids expressing chimeric SMOC proteins that have the worm SMOC-1 signal peptide (CelSP) followed by the extracellular region of hSMOC1 or hSMOC2 ( Figure 8A and Table 2 ). Both CelSP::hSMOC1 and CelSP::hSMOC2 partially rescued the Susm phenotype of smoc-1(tm7125) mutants ( Figure 8B ), but failed to rescue the body size phenotype ( Figure 8C ). Nevertheless, these results demonstrate that CelSP:hSMOC1 and CelSP:hSMOC2 can function to regulate BMP signaling in C. elegans, and suggest that the function of SMOC proteins in regulating BMP signaling is evolutionarily conserved from worms to humans.
Discussion
In this study, we identified the sole SMOC protein in C. elegans, which belongs to the SPARC/BM40 family of matricellular proteins, as a key player in the BMP signaling pathway. smoc-1(0) mutations cause a reduction in body size and suppress the sma-9(0) M-lineage defect, but smoc-1(0) mutants are not as small as null mutants in core components of the BMP pathway (Figure 1, Figure 2, Figure 3 , and Table 3 ). These phenotypes resemble those caused by mutations in other modulators of the BMP pathway, such as DRAG-1/ RGM (Tian et al. 2010) , TSP-21 (Liu et al. 2015) , or SUP-17/ADAM10 (Wang et al. 2017) , and are consistent with a modulatory role for SMOC-1 in the BMP pathway. Over-or 0.3 6 1.0 (313) 97.9 6 26.0 (570) 100 (853) daf-1(m213); lon-2(e678) #1 0.2 6 0.3 (575) 92.1 6 2.9 (643) 100 (1149) daf-1(m213); lon-2(e678) #2 0.5 6 0.8 (654) 77.7 6 5.0 (515) 100 (832) n, number of worms scored at each temperature; from a total of five plates per genotype assayed at each condition. For each double-mutant combination, two independent isolates (#1 and #2) were examined. % Daf-c, mean dauer formation percentage 6 SD. a P , 0.05, as calculated by an ANOVA and Tukey's honest significant difference, between a double mutant and the corresponding daf single mutant at the specified temperature.
ectopic expression of smoc-1 led to a significant increase in body size, and an increase in RAD-SMAD reporter expression. Moreover, the long body size phenotype caused by smoc-1(OE) is completely suppressed by null mutations in the BMP ligand DBL-1 and the R-Smad SMA-3 ( Figure 4 and Figure 7B ). Collectively, these findings demonstrate that SMOC-1 functions through the BMP ligand DBL-1 and acts as a positive modulator to promote BMP signaling. Importantly, the expression of smoc-1 in the intestine is positively regulated by BMP signaling (Figure 6 ). Thus, SMOC-1 functions in a positive feedback loop in the BMP pathway. We speculate that this mode of feedback regulation ensures robustness of BMP signaling. How might SMOC-1 function to promote BMP signaling? Our tissue-specific rescue data coupled with the expression pattern of smoc-1 ( Figure 6 and Figure 7) showed that SMOC-1 functions cell nonautonomously to regulate BMP signaling. This is consistent with SMOC-1 being a predicted secreted protein. Strikingly, forced expression of smoc-1 exclusively in pharyngeal muscles is sufficient to rescue both the body size and the Susm phenotype of smoc-1(0) mutants (Figure 7) . Notably, the M-lineage cells, where the Smad proteins function to regulate M-lineage development (Foehr et al. 2006) , are located in the posterior of a developing larva, distant from the pharynx. Thus, SMOC-1 can function over long distances, from a source located far from BMP-receiving cells, to regulate the output of BMP signaling.
The Drosophila homolog of SMOC-1, Pent, can also function over long distances to regulate Dpp/BMP signaling in the developing wing imaginal discs (Vuilleumier et al. 2010) . In particular, Pent has been shown to bind to and induce the internalization of the BMP coreceptor Dally/glypican [a heparan sulfate proteoglycan (HSPG)], such that the trapping of Dpp/BMP by Dally is reduced, which in turn promotes the spreading of Dpp/BMP (Norman et al. 2016) . Using a Xenopus animal cap transfer assay, Thomas and colleagues (Thomas et al. 2017) showed that Xenopus SMOC-1 can also expand the range of BMP signaling by competing with BMP to bind to HSPGs. In C. elegans, the glypican homolog LON-2 is a known negative regulator of BMP signaling. LON-2 can bind to BMP in vitro, and has been proposed to function in the signal-receiving cells, the hypodermal cells, to negatively regulate BMP signaling by sequestering the DBL-1/BMP ligand (Gumienny et al. 2007) . Our genetic analysis between lon-2(0) and smoc-1(0) mutations suggests that SMOC-1 antagonizes the function of LON-2 in regulating BMP signaling ( Figure 5A ). How SMOC-1 and LON-2 can functionally antagonize each other is currently unknown. One possible model is that the two proteins function completely independently to regulate BMP signaling. Alternatively, based on the observed physical interaction between HSPG and the Drosophila and Xenopus SMOC homologs, one can envision that SMOC-1 may promote BMP signaling by binding to LON-2/glypican and inhibiting LON-2's ability to sequester the DBL-1/BMP ligand. However, SMOC-1 must have LON-2/ glypican-independent function(s), because smoc-1(OE) can further increase body size in the absence of LON-2/glypican, as in smoc-1(OE); lon-2(0) double mutants shown in Figure  5B , and smoc-1(0); lon-2(0) double mutants exhibit an intermediate body length between those of each single mutant.
The molecular mechanism underlying the LON-2/glypicanindependent function of SMOC-1 is currently unknown. In addition to LON-2, there are five other HSPG-encoding genes in the C. elegans genome: unc-52, cle-1, gpn-1, sdn-1, Figure 6 smoc-1 is expressed in multiple tissues and its intestinal expression is positively regulated by BMP signaling. (A) Expression of smoc-1 cDNA under different regulatory elements to test for rescue of the body size phenotype of smoc-1(tm7125) worms. For each construct, two independent transgenic lines were examined, and the data were combined and averaged. Body sizes are relative to smoc-1(tm7125) mutant worms (set to 1.0) and all measurements were done on the same day. Error bars represent 95% C.I. *** P , 0.0001. (B-F) Merged GFP and DIC images of WT worms (B-E) and a sma-6(jj1) mutant worm (F) carrying the integrated smoc-1 transcriptional reporter jjIs4688 (Table 1) . In WT embryos, GFP expression is detectable at the bean stage (E). In developing WT larvae, GFP expression is detectable in the pharynx (B and C), intestine (B), and posterior hypodermis (B and D). GFP expression in the intestine, but not in the pharynx or posterior hypodermis, is significantly reduced in sma-6(jj1) larvae (F). Images are side views with anterior to the left and dorsal up. (G) Proportions of WT and mutant worms with intestinal expression of the smoc-1 transcriptional reporter. Two independent isolates were assessed for each gene tested. WT, wild-type. and agr-1 (Rogalski et al. 1993; Halfter et al. 1998; Ackley et al. 2001; Rhiner et al. 2005; Hrus et al. 2007) . It is possible that in addition to LON-2/glypican, one or multiple of these other HSPGs also functions with SMOC-1 to regulate BMP signaling. Alternatively, SMOC-1 may promote BMP signaling by interacting with other cell surface or extracellular BMP regulators, or even with DBL-1/BMP itself, to promote BMP signaling. Any LON-2/glypican-independent function of SMOC-1 still requires DBL-1/BMP, because smoc-1(OE); dbl-1(0) double mutants are as small as dbl-1(0) null mutants. Our model, proposing that SMOC-1 has dual modes of action to regulate BMP signaling, is consistent with structure-function analysis of Xenopus SMOC-1 (XSMOC-1), whose EC domains can bind to HSPG and promote BMP Figure 7 smoc-1 functions cell nonautonomously to regulate body size and M-lineage development. Tissue-specific expression of smoc-1 cDNA to test for rescue of the body size (A) or Susm (C) phenotype of smoc-1(tm7125) worms. smoc-1 cDNA was driven by each specific promoter to allow expression in a given tissue. All constructs used the unc-54 39-UTR. For each construct, two independent transgenic lines were examined and the measurements were averaged. (A) Body sizes are relative to smoc-1(tm7125) mutant worms (set to 1.0) and all measurements were done on the same day. (B) Relative body length of developmental stage-matched WT and dbl-1(ok3749) worms that either carry or do not carry the jjEx4849[myo-2p::smoc-1 cDNA::unc-54 39UTR] transgene. Body sizes are relative to WT worms (set to 1.0) and all measurements were done on the same day. (A and B) Error bars represent 95% C.I. An ANOVA followed by Tukey's honest significant difference was used to test for differences in body size between groups. (C) The Susm phenotype was scored in the background of smoc-1(tm7125); sma-9(cc604); CC::gfp. A Wald test was used to determine if transgenic state is associated with CC number. Error bars represent SE. ** P , 0.001 and *** P , 0.0001. CC, coelomocyte; ND, no difference; Susm, suppression of sma-9(0) M-lineage defect; WT, wild-type.
Figure 8
Human SMOC proteins can partially rescue the Susm phenotype of smoc-1(0) mutants. (A) Schematics of SMOC homologs tested for function in C. elegans. Solid black outline indicates C. elegans protein sequences. Dashed gray line indicates human protein sequences. All ORFs were cloned into the same vector with the same regulatory elements (2-kb smoc-1 promoter and unc-54 39-UTR), and each construct was tested for the rescue of Susm (B) and body size (C) phenotype of smoc-1(tm7125) mutants. Two independent lines were assayed for each construct. (B) The Susm phenotype was scored in the background of smoc-1(tm7125); sma-9(cc604); CC::gfp. A Wald test was used to determine if transgenic state is associated with CC number. Error bars represent SE. (C) Body sizes are relative to WT worms (set to 1.0), and all measurements were done on the same day. An ANOVA followed by Tukey's honest significant difference was used to test for differences between groups. Error bars represent 95% C.I. * P , 0.01, ** P , 0.001, and *** P , 0.0001. CC, coelomocyte; EC, secreted protein acidic and rich in cysteine (SPARC) extracellular calcium-binding domain; FS, follistatin-like domain; ND, no difference; SP, signal peptide; Susm, suppression of sma-9(0) M-lineage defect; TY, thyroglobulin type I-like repeat WT, wild-type. spreading, while the TY domains are necessary for XSMOC-1 to inhibit BMP signaling (Thomas et al. 2017) . We have shown that both the TY and EC domains in C. elegans SMOC-1 are important for its function in BMP signaling, because mutations in either domain disrupt the function of SMOC-1 ( Figure 2 ). Further dissection of the roles of each of these domains at the molecular level will help clarify the mechanisms underlying SMOC-1 function in the BMP pathway.
In this study, we have shown that in addition to being a positive regulator of BMP signaling, smoc-1 is also positively regulated by BMP signaling at the transcriptional level (Figure 6) . In Drosophila, Pent transcription is directly regulated by BMP signaling via the silencer elements that are bound by the Smad-Shn repressive complex (Vuilleumier et al. 2010) . Whether smoc-1 is directly or indirectly regulated by BMP signaling in C. elegans remains to be determined. Nevertheless, our results suggest a model in which SMOC-1 functions in a positive feedback loop to regulate BMP signaling ( Figure  9 ). We argue that this mode of regulatory relationship between SMOC-1 and the BMP pathway ensures robustness of BMP signaling in processes that require high levels of BMP signaling. Consistent with this notion, smoc-1(0) mutants exhibit a smaller body size, but do not appear to have major defects in the male tail, a process previously known to require a lower threshold of BMP signaling .
Human SMOC1 can bind to the TGFb coreceptor endoglin to regulate TGFb signaling in endothelial cells (Awwad et al. 2015) . Our genetic analysis suggests that SMOC-1 does not play a key role, but may play a minor or modulatory role, in regulating the TGFb-like dauer pathway in C. elegans (Table  4 ). Because the BMP pathway and the TGFb-like dauer pathway share DAF-4 as the sole type II receptor in C. elegans, there might be low levels of cross talk between these two pathways, which has been previously documented for other BMP pathway mutations Maduzia et al. 2005; Tian et al. 2010) .
In addition to their roles in regulating BMP signaling, SMOC-1 homologs have also been found to function in other signaling pathways. Pent has been shown to play a role in regulating Wg signaling in the Drosophila wing (Norman et al. 2016) . SMOC2 can potentiate endothelial growth factor or fibroblast growth factor activity to promote angiogenesis in cultured human umbilical vein endothelial cells (Rocnik et al. 2006) . Whether SMOC-1 is involved in other signaling pathways in C. elegans is currently unknown.
There are two SMOC homologs in mammals. SMOC1 is essential for eye and limb development in mice, and mutations in SMOC1 in humans cause microphthalmia with limb anomalies and ophthalmo-acromelic syndrome (also known as Waardenburg anophthalmia syndrome), both of which affect eye and limb development (Okada et al. 2011; Rainger et al. 2011) . Mutations in hSMOC2 have also been found to be associated with defects in dental development (Bloch-Zupan et al. 2011; Alfawaz et al. 2013 ) and vitiligo (Alkhateeb et al. 2010; Birlea et al. 2010) . QTL mapping in different dog breeds has found that a retrotransposon insertion that disrupts SMOC2 splicing and reduces its expression is associated with canine brachycephaly (Marchant et al. 2017) . In addition, several different types of brain tumors exhibit altered expression of SMOC1 (Brellier et al. 2011) , while SMOC2 is an intestinal stem cell signature gene (Muñoz et al. 2012) that is required for L1-mediated colon cancer progression (Shvab et al. 2016) . Notably, BMP signaling is known to play important roles in eye, tooth, and limb development, and abnormal BMP signaling can cause cancer (Thawani et al. 2010) . Here, we have demonstrated that both hSMOC1 and hSMOC2 can partially rescue the Susm phenotype of smoc-1(0) mutants (Figure 8 ), suggesting that the function of SMOC proteins in regulating BMP signaling is evolutionarily conserved. Future studies on how SMOC-1 functions to regulate BMP signaling in an in vivo system such as C. elegans may have implications for human health. 
